New insights into the neuroimmunity of SIV infection by magnetic resonance spectroscopy

Journal of Neuroimmune Pharmacology

Volumn 1, Issue 2, 2006, Pages 152-159

  González, R Gilberto ^a,b   Greco, Jane B ^a,b   He, Julian ^a,b   Lentz, Margaret R ^a,b   O'Neil, Shawn ^a   Pilkenton, Sarah J ^a,b   Ratai, Eva M ^a,b   Westmoreland, Susan ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AIDS; CD8 T lymphocyte; CNS; Highly active antiretroviral therapy (HAART); HIV associated dementia; Macrophages; Monocytes; MR spectroscopy; N acetylaspartate (NAA); NeuroAIDS; Simian immunodeficiency virus (SIV); SIV encephalitis

Indexed keywords

ANIMAL; CD8+ T LYMPHOCYTE; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE DEPLETION; MACACA; MACROPHAGE; MONKEY DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; LYMPHOCYTE DEPLETION; MACACA MULATTA; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; NEUROIMMUNOMODULATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 33747469551     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-006-9016-4     Document Type: Review

References (55)

1. Avison MJ, Nath A, Berger JR (2002) Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci 25:468-473
2. Barker PB, Lee RR, McArthur JC (1995) AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 195:58-64
3. Baslow MH (2000) Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem 75:453-459
4. Boska MD, Mosley RL, Nawab M, Nelson JA, Zelivyanskaya M, Poluektova L, Uberti M, Dou H, Lewis TB, Gendelman HE (2004) Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoring. Curr HIV Res 2:61-78
5. Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333-348
6. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E (1999a) Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 52:100-108
7. Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, Miller EN (1999b) Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53:782-789
8. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonzalez RG (1997) Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 94:6408-6413
9. Cheng LL, Newell K, Mallory AE, Hyman BT, Gonzalez RG (2002) Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology. Magn Reson Imaging 20:527-533
10. Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, Shepard JK, Beecham M, Miller RF, Weller IV (1993) Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 188:119-124
11. Di Giambenedetto S, Vago G, Pompucci A, Scoppettuolo G, Cingolani A, Marzocchetti A, Tumbarello M, Cauda R, De Luca A (2004) Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? Neurology 63:2452-2453
12. Enting RH, Hoetelmans RM, Lange JM, Burger DM, Beijnen JH, Portegies P (1998) Antiretroviral drugs and the central nervous system. AIDS 12:1941-1955
13. Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W (2001) Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 22:277-283
14. Fox HS, Weed MR, Huitron-Resendiz S, Baig J, Horn TF, Dailey PJ, Bischofberger N, Henriksen SJ (2000) Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest 106:37-45
15. Fuller RA, Westmoreland SV, Ratai E, Greco JB, Kim JP, Lentz MR, He J, Sehgal PK, Masliah E, Halpern E, Lackner AA, Gonzalez RG (2004) A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS. BMC Neurosci 5:10
16. Gonzalez RG, Cheng LL, Westmoreland SV, Sakaie KE, Becerra LR, Lee PL, Masliah E, Lackner AA (2000) Early brain injury in the SIV-macaque model of AIDS. AIDS 14:2841-2849
17. Govindaraju V, Young K, Maudsley AA (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13:129-153
18. Greco JB, Sakaie KE, Aminipour S, Lee PL, Chang LL, He J, Westmoreland S, Lackner AA, Gonzalez RG (2002) Magnetic resonance spectroscopy: an in vivo tool for monitoring cerebral injury in SIV-infected macaques. J Med Primatol 31:228-236
19. Greco JB, Westmoreland SV, Ratai EM, Lentz MR, Sakaie K, He J, Sehgal PK, Masliah E, Lackner AA, Gonzalez RG (2004) In vivo 1H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS. Magn Reson Med 51:1108-1114
20. Haase A, Frahm J, Hanicke W, Matthaei D (1985) 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30:341-344
21. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I (1993) Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 186:739-744
22. Jarvik JG, Lenkinski RE, Saykin AJ, Jaans A, Frank I (1996) Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. J Acquir Immune Defic Syndr Human Retrovirol 13:247-253
23. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994
24. Lacroix S, Rivest S (1998) Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 70:452-466
25. Lacroix S, Feinstein D, Rivest S (1998) The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol 8:625-640
26. Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, Hennig J, Langer M (1996) HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 199:805-810
27. Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, Gonzalez RG, Navia BA (2003) A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 17:625-633
28. Lentz MR, Kim JP, Westmoreland SV, Greco JB, Fuller RA, Ratai EM, He J, Sehgal PK, Halpern EF, Lackner AA, Masliah E, Gonzalez RG (2005) Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain. Radiology 235:461-468
29. Lopez-Villegas D, Lenkinski RE, Frank I (1997) Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci USA 94:9854-9859
30. Madden LJ, Zandonatti MA, Flynn CT, Taffe MA, Marcondes MC, Schmitz JE, Reimann KA, Henriksen SJ, Fox HS (2004) CD8+ cell depletion amplifies the acute retroviral syndrome. J Neurovirol 10:58-66
31. Mathew RM, Murnane M (2004) MRI in PML: bilateral medullary lesions. Neurology 63:2380
32. McConnell JR, Swindells S, Ong CS, Gmeiner WH, Chu WK, Brown DK, Gendelman HE (1994) Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res Hum Retrovir 10:977-982
33. Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA, Baudouin CJ, Kocsis AE, Harris JR (1992) Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 16:538-542
34. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G (1993) Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43:509-515
35. Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G (1999) Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 52:995-1003
36. Nelson JA, Dou H, Ellison B, Uberti M, Xiong H, Anderson E, Mellon M, Gelbard HA, Boska M, Gendelman HE (2005) Coregistration of quantitative proton magnetic resonance spectroscopic imaging with neuropathological and neurophysiological analyses defines the extent of neuronal impairments in murine human immunodeficiency virus type-1 encephalitis. J Neurosci Res 80:562-575
37. Podell M, Maruyama K, Smith M, Hayes KA, Buck WR, Ruehlmann DS, Mathes LE (1999) Frontal lobe neuronal injury correlates to altered function in FIV-infected cats. J Acquir Immune Defic Syndr 22:10-18
38. Pomara N, Crandall DT, Choi SJ, Johnson G, Lim KO (2001) White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 106:15-24
39. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ (1997) Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Hum Retrovir 13:1055-1066
40. Schinazi RF, Boudinot FD, Ibrahim SS, Manning C, McClure HM, Liotta DC (1992) Pharmacokinetics and metabolism of racemic 2′,3′-dideoxy-5- fluoro-3′-thiacytidine in rhesus monkeys. Antimicrob Agents Chemother 36:2432-2438
41. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA (1999a) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860
42. Schmitz JE, Simon MA, Kuroda MJ, Lifton MA, Ollert MW, Vogel CV, Racz P, Tenner-Racz K, Scallon BJ, Dalesandro M, Ghrayeb J, Rieber EP, Sasseville VG, Reimann KA (1999b) A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 154:1923-1932
43. Stankoff B, Tourbah A, Suarez S, Turell E, Stievenart JL, Payan C, Coutellier A, Herson S, Baril L, Bricaire F, Calvez V, Cabanis EA, Lacomblez L, Lubetzki C (2001) Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 56:112-115
44. Stenzel W, Pels H, Staib P, Impekoven P, Bektas N, Deckert M (2004) Concomitant manifestation of primary CNS lymphoma and Toxoplasma encephalitis in a patient with AIDS. J Neurol 251:764-766
45. Szeto ER, Freund J, Brew BJ, Loder A, Griffiths MR (1998) Cerebral perfusion scanning in treating AIDS dementia: a pilot study. J Nucl Med 39:298-302
46. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG (1996) Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 46:783-788
47. Tracey I, Lane J, Chang I, Navia BA, Lackner AA, Gonzalez RG (1997) 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model. J Acquir Immune Defic Syndr Hum Retrovirol 15:21-27
48. Tracey I, Hamberg LM, Guimaraes AR, Hunter G, Chang I, Navia BA, Gonzalez RG (1998) Increased cerebral blood volume in HIV-positive patients detected by functional MRI. Neurology 50:1821-1826
49. Tsai CC, Follis KE, Sabo A, Beck TW, Grant RF, Bischofberger N, Benveniste RE, Black R (1995) Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science 270:1197-1199
50. Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55-61
51. Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981-989
52. von Giesen HJ, Antke C, Hefter H, Wenserski F, Seitz RJ, Arendt G (2000) Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch Neurol 57:1601-1607
53. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE (1994) Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 31:365-373
54. Williams K, Westmoreland S, Greco J, Ratai E, Lentz M, Kim WK, Fuller RA, Kim JP, Autissier P, Sehgal PK, Schinazi RF, Bischofberger N, Piatak JM, Lifson JD, Masliah E, Gonzalez RG (2005) Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest 115:2534-2545
55. Yiannoutsos CT, Ernst T, Chang L, Lee PL, Richards T, Marra CM, Meyerhoff DJ, Jarvik JG, Kolson D, Schifitto G, Ellis RJ, Swindells S, Simpson DM, Miller EN, Gonzalez RG, Navia BA (2004) Regional patterns of brain metabolites in AIDS dementia complex. NeuroImage 23:928-935